Skip to content

Clinical trials

Phase 1 Lung Neoplasms trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 1 Country / region: Spain Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20133
20141
20151
20162
20173
20194
20215
20224
20246
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting8
Recruiting8
Terminated7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Eli Lilly and Company3
Pfizer3
AbbVie2
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)2
Amgen1
Anaveon AG1
AstraZeneca1
BeOne Medicines1
Black Diamond Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms35
Carcinoma, Non-Small-Cell Lung22
Neoplasms14
Breast Neoplasms9
Colonic Neoplasms9
Colorectal Neoplasms8
Neoplasm Metastasis8
Ovarian Neoplasms7
Stomach Neoplasms7
Endometrial Neoplasms6

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.